# FDA recall D-0073-2023

> **Dr. Reddy's Laboratories, Inc.** · Class III · drug recall initiated 2022-11-21.

## Product

Allergy Relief D, Fexofenadine HCL 60mg/Antihistamine, Pseudoephedrine HCL 120mg/Nasal Decongestant, Extended-Release Tablets USP, packaged as (a) 20 count carton NDC 49032-273-20; (b) 30 count carton, NDC49032-273-30; Distributed by: Walmart Inc., Bentonville, AR 72716, Product of India

## Reason for recall

Failed dissolution specifications

## Distribution

Nationwide in the USA

## Key facts

- **Recall number:** D-0073-2023
- **Recalling firm:** Dr. Reddy's Laboratories, Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-11-21
- **Report date:** 2022-12-07
- **Termination date:** 2024-08-28

- **Voluntary/Mandated:** —
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0073-2023

## Citation

> AI Analytics. FDA recall D-0073-2023. Retrieved 2026-06-12 from https://api.ai-analytics.org/recall/D-0073-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*